3 ms·
Two concrete examples of this I can think of are 1) use of Psylocibin (mushrooms) assisted Congitive Behavioural Therapy for curing PTSD, depression, anxiety,
by enragedcacti 5y ago
Two concrete examples of this I can think of are
1) use of Psylocibin (mushrooms) assisted Congitive Behavioural Therapy for curing PTSD, depression, anxiety, etc. we have seen extremely good results from this and pharma companies could have likely pushed it much much sooner
2) Biofeedback/Neurofeedback has been around for more than a decade and is under-researched, under-insured, and under-prescribed for treatment of a lot of mental issues from anxiety to post-concussive syndrome to ADHD.
both of these can negate the need for a years or decades long reliance on SSRIs or stimulants.
- TheLegace 5y agoI can tell you from first hand experience that neurofeedback is a life changing treatment. Far superior to ADHD stimulants which is a nightmare for some.
- Closi 5y agoI don’t think it’s pharma companies responsibility to ‘push’ psylocibin - it sounds like that sits more between doctors, public/university pharmaceutical researchers and legislators.
- dekhn 5y agoSandoz's original explorations into LSD were medically focused and it was marketed (and distributed for free in high purity) for psychiatric indications, but after it grew in popularity an illicit drug, all pharma got out of the business of working with highly psychoactive compounds for decades because of the negative press assocations.